Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Treasury Shares: 2009-2024

Historic Treasury Shares for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Dec 2024 value amounting to $2.7 million.

  • Vanda Pharmaceuticals' Treasury Shares rose 27.78% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 27.78%. This contributed to the annual value of $2.7 million for FY2024, which is 39.09% up from last year.
  • Latest data reveals that Vanda Pharmaceuticals reported Treasury Shares of $2.7 million as of FY2024, which was up 39.09% from $1.9 million recorded in FY2023.
  • Vanda Pharmaceuticals' 5-year Treasury Shares high stood at $2.7 million for FY2024, and its period low was $1.6 million during FY2020.
  • Its 3-year average for Treasury Shares is $2.2 million, with a median of $1.9 million in 2022.
  • Its Treasury Shares has fluctuated over the past 5 years, first decreased by 0.59% in 2020, then spiked by 39.09% in 2024.
  • Over the past 5 years, Vanda Pharmaceuticals' Treasury Shares (Yearly) stood at $1.6 million in 2020, then grew by 7.63% to $1.8 million in 2021, then climbed by 8.55% to $1.9 million in 2022, then fell by 0.53% to $1.9 million in 2023, then surged by 39.09% to $2.7 million in 2024.